These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9664159)

  • 1. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.
    Molina MS; Hoffman EA; Stokes J; Kummet N; Smith KA; Baker F; Zúñiga TM; Simpson RJ; Katsanis E
    Front Immunol; 2021; 12():699128. PubMed ID: 34249005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive and rapid chemiluminescence immunoassay for point-of-care testing (POCT) of copeptin in serum based on high-affinity monoclonal antibodies via cytokine-assisted immunization.
    Wang Y; Dzakah EE; Kang Y; Cai Y; Wu P; Tang B; Li R; He X
    Int J Nanomedicine; 2019; 14():4293-4307. PubMed ID: 31354261
    [No Abstract]   [Full Text] [Related]  

  • 3. Barley as a green factory for the production of functional Flt3 ligand.
    Erlendsson LS; Muench MO; Hellman U; Hrafnkelsdóttir SM; Jonsson A; Balmer Y; Mäntylä E; Orvar BL
    Biotechnol J; 2010 Feb; 5(2):163-71. PubMed ID: 19844912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of sorafenib in the treatment of acute myeloid leukemia.
    Mori S; Cortes J; Kantarjian H; Zhang W; Andreef M; Ravandi F
    Leuk Lymphoma; 2008 Dec; 49(12):2246-55. PubMed ID: 19052971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
    Quittet P; Ceballos P; Lopez E; Lu ZY; Latry P; Becht C; Legouffe E; Fegueux N; Exbrayat C; Pouessel D; Rouillé V; Daures JP; Klein B; Rossi JF
    Bone Marrow Transplant; 2006 Aug; 38(4):275-84. PubMed ID: 16883311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.
    Whartenby KA; Calabresi PA; McCadden E; Nguyen B; Kardian D; Wang T; Mosse C; Pardoll DM; Small D
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16741-6. PubMed ID: 16272221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis.
    Lamming CE; Augustin L; Blackstad M; Lund TC; Hebbel RP; Verfaillie CM
    J Clin Invest; 2003 Mar; 111(6):811-9. PubMed ID: 12639987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic effects and potential clinical applications of Flt3 ligand.
    Lyman SD
    Curr Opin Hematol; 1998 May; 5(3):192-6. PubMed ID: 9664159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and potential clinical applications of flt3 ligand.
    Lyman SD; Williams DE
    Curr Opin Hematol; 1995 May; 2(3):177-81. PubMed ID: 9371992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of flt3 ligand and receptor.
    Lyman SD
    Int J Hematol; 1995 Aug; 62(2):63-73. PubMed ID: 8590775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
    Lyman SD; Brasel K; Rousseau AM; Williams DE
    Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.
    Namikawa R; Muench MO; Roncarolo MG
    Stem Cells; 1996 Jul; 14(4):388-95. PubMed ID: 8843540
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.